We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.95B
AUM Growth
-$232M
Cap. Flow
-$467M
Cap. Flow %
-9.44%
Top 10 Hldgs %
11.79%
Holding
1,100
New
153
Increased
294
Reduced
399
Closed
191

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$28.6M
2
INTU icon
Intuit
INTU
+$27.6M
3
EA icon
Electronic Arts
EA
+$23.2M
4
QCOM icon
Qualcomm
QCOM
+$22.5M
5
CVX icon
Chevron
CVX
+$19.1M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.2M
2
AAPL icon
Apple
AAPL
+$38.4M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$37.2M
4
AMD icon
Advanced Micro Devices
AMD
+$26.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$25.2M

Sector Composition

Rank Sector Weight
1 Technology 20.09%
2 Financials 17.69%
3 Healthcare 13.21%
4 Industrials 12.31%
5 Consumer Discretionary 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ULBI icon
876
Ultralife
ULBI
$88.3M
$76K ﹤0.01%
13,951
-4,200
-23% -$22.9K
DALN
877
DELISTED
DallasNews
DALN
$75K ﹤0.01%
3,054
-1,239
-29% -$31.3K
PAR icon
878
PAR Technology
PAR
$637M
$75K ﹤0.01%
10,488
-9,785
-48% -$63.2K
PSTV icon
879
Plus Therapeutics
PSTV
$26.4M
– –
0
– –
ECYT
880
DELISTED
Endocyte, Inc. Common Stock
ECYT
$74K ﹤0.01%
28,627
-47,747
-63% -$110K
CPIX icon
881
Cumberland Pharmaceuticals
CPIX
$99M
$73K ﹤0.01%
10,550
– –
ZAGG
882
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$72K ﹤0.01%
+10,053
New +$67.5K
ADVM
883
DELISTED
Adverum Biotechnologies
ADVM
$66K ﹤0.01%
+2,445
New +$69.5K
TCON
884
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$66K ﹤0.01%
88
-56
-39% -$50.2K
FCSC
885
DELISTED
Fibrocell Science Inc.
FCSC
$64K ﹤0.01%
+6,448
New +$71.5K
XRM
886
DELISTED
Xerium Technologies Inc (new)
XRM
$64K ﹤0.01%
10,001
-15,797
-61% -$85.5K
ENPH icon
887
Enphase Energy
ENPH
$4.84B
$59K ﹤0.01%
43,194
-43,700
-50% -$63.6K
OESX icon
888
Orion Energy Systems
OESX
$41.1M
$59K ﹤0.01%
2,974
-670
-18% -$13.4K
CLD
889
DELISTED
Cloud Peak Energy Inc
CLD
$59K ﹤0.01%
12,898
– –
EGAN icon
890
eGain
EGAN
$176M
$58K ﹤0.01%
39,866
– –
EGY icon
891
Vaalco Energy
EGY
$594M
$57K ﹤0.01%
62,498
+49,489
+380% +$53.3K
SUNE
892
SUNation Energy
SUNE
$9.9M
– –
0
– –
KSPN
893
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$53K ﹤0.01%
+1,559
New +$82.9K
VXRT
894
DELISTED
Vaxart
VXRT
$52K ﹤0.01%
7,254
-873
-11% -$8.93K
SPRT
895
DELISTED
support.com, Inc.
SPRT
$52K ﹤0.01%
23,682
-11,860
-33% -$26.6K
ICAD
896
DELISTED
iCAD Inc
ICAD
$51K ﹤0.01%
10,705
-26,492
-71% -$103K
CASC
897
DELISTED
Cascadian Therapeutics, Inc.
CASC
$51K ﹤0.01%
+12,400
New +$52.1K
YUME
898
DELISTED
YuMe, Inc.
YUME
$43K ﹤0.01%
10,600
-1,000
-9% -$3.64K
AVEO
899
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$42K ﹤0.01%
7,140
-21,813
-75% -$158K
ARQL
900
DELISTED
Arqule Inc
ARQL
$39K ﹤0.01%
36,852
– –
34 35
36
37 38

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q1 2017 Portfolio in Review

As of Q1 2017, Jacobs Levy Equity Management held 1,100 positions worth $4.95B, down 4.5% from $5.18B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management withdrew a net $467M in Q1 2017, closing 191 positions and reducing 399 holdings. Its most notable exit was VMware, Inc, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Intuit worth $26.7M.

  • Jacobs Levy Equity Management's largest Q1 2017 buy was Intuit: 229,923 shares worth $26.7M.
  • Jacobs Levy Equity Management added most to Celgene Corp in Q1 2017, an estimated $28.6M increase.
  • Jacobs Levy Equity Management's biggest Q1 2017 reduction was Amgen, cutting an estimated $41.2M.
  • Jacobs Levy Equity Management fully exited VMware, Inc in Q1 2017, selling an estimated $22.6M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $4.95B portfolio in Q1 2017.
  • Jacobs Levy Equity Management opened 153 new positions and closed 191 in Q1 2017.
  • Jacobs Levy Equity Management's portfolio value fell 4.5% quarter-over-quarter to $4.95B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2017, filed 15 May 2017.